A carregar...
Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
Multidrug resistance (MDR) is one of conventional cancer chemotherapy’s limitations. Our group previously synthesized a series of quinoline-based compounds in an attempt to identify novel anticancer agents. With a molecular docking analysis, the novel compound 160a was predicted to target p-glycopro...
Na minha lista:
| Publicado no: | Biology (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955663/ https://ncbi.nlm.nih.gov/pubmed/31581572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology8040075 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|